| EPB231 | Inhibitory, KIR/HLA-mismatched, allogeneic NK and γδ-T cells as an HIV cure strategy: proof-of-concept in 3 patients | E-poster | Cure interventions |
| EPB232 | In vitro evaluation of drug-loaded polymeric nanoparticles in the treatment of Human Immunodeficiency Virus | E-poster | Cure interventions |
| EPB233 | Impact of HIV status on nutritional outcomes in hospitalized Mozambican children | E-poster | Nutrition |
| EPB234 | Preventing HIV positive childhood Malnutrition through mothers /caregivers' education on home-made high protein diet amongst Internally Displaced Persons (IDPs) in the conflict zone of the North West Region of Cameroon | E-poster | Nutrition |
| EPB235 | Resistance mutations in the HIV integrase coding region among INSTI-naïve pregnant women in Argentina: a baseline survey | E-poster | Resistance to ART |
| EPB236 | Transmitted HIV-1 drug resistance in a RAPID ART initiation cohort Panama 2018'2020 | E-poster | Resistance to ART |
| EPB237 | Factors associated with Antiretroviral therapy failure among persons living with HIV in Zambia, 2013'2020 ' A retrospective cohort study | E-poster | Resistance to ART |
| EPB238 | Temporal trends of pediatric HIV drug resistance and subtype in Brazil (2009-2020) | E-poster | Resistance to ART |
| EPB239 | Resistance analysis of long-acting lenacapavir in treatment-naïve people with HIV at 54 weeks | E-poster | Resistance to ART |
| EPB240 | Resistance analysis of long-acting Lenacapavir in highly treatment-experienced people with HIV after 52 weeks of treatment | E-poster | Resistance to ART |